Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
{{output}}
Acute myeloid leukemia (AML) carrying nucleophosmin (NPM1) mutations displays distinct molecular and clinical-pathological features that led to its inclusion as provisional entity in 2008 WHO classification of myeloid neoplasms. Since NPM1 mutations behave as ... ...
